Q: There is a lot of media coverage about CBD, and it seems to be appearing all over the place. Who is buying all the CBD products?
A: CBD stands for cannabidiol, the second-most popular among active ingredients of the cannabis sativa plant. Cannabis contains hundreds of cannabinoids, each of which presents unique qualities and potential benefits.
recent Gallup survey found that one in seven Americans report using CBD for a range of medical and therapeutic purposes.” data-reactid=”29″>CBD is used by all types of consumers, purchasing CBD-infused products for a variety of reasons. A recent Gallup survey found that one in seven Americans report using CBD for a range of medical and therapeutic purposes.
With passage of the 2018 U.S. Farm Bill which federally legalized hemp for the first time since World War II, the market for hemp-derived CBD products has seen explosive growth. Mass-marketed, hemp-derived CBD products have found their way onto retail shelves everywhere from grocery stores, coffee shops, and cosmetics retailers to veterinarians’ offices and nutritional supplement shops nationwide.
there remains confusion regarding to what extent CBD is legal. The DEA has asserted that only GW Pharmaceutical’s patented Epidiolex is legally permitted to incorporate CBD oil in products. Yet attorney Garrett Graff of Hoban Law Group, who specializes in cannabis law and is part of a group who brought an appeal against the DEA ruling, has challenged that.” data-reactid=”31″>That said, there remains confusion regarding to what extent CBD is legal. The DEA has asserted that only GW Pharmaceutical’s patented Epidiolex is legally permitted to incorporate CBD oil in products. Yet attorney Garrett Graff of Hoban Law Group, who specializes in cannabis law and is part of a group who brought an appeal against the DEA ruling, has challenged that.
„It’s our understanding that cannabinoids derived from industrial hemp so long as below the 0.3 percent THC threshold are, in fact, lawful pursuant to the farm bill under federal law,” Graff posited. Since the FDA has not approved any CBD products at all, „at this point, we simply agree to disagree, and those products remain on the marketplace,” he explained.
Findings from the research indicate that nearly a third (30%) of cannabis consumers are using CBD products, or nearly twice the previously reported rate among the general population. Such consumers also tend to be women (57%), especially under the age of 35 (43%), consistent with much of the current marketing of CBD products as health and wellness brand targeted specifically to women consumers.
Other key insights from the report found that: